• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东地区(EMRO)国家炎症性肠病的流行病学特征:系统评价和荟萃分析。

Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis.

机构信息

Assistant Professor of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, Iran.

Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Public Health. 2024 May 24;24(1):1395. doi: 10.1186/s12889-024-18816-z.

DOI:10.1186/s12889-024-18816-z
PMID:38789987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11127456/
Abstract

BACKGROUND

Inflammatory bowel disease (IBD) consists of two main types: Crohn's disease (CD) and ulcerative colitis (UC). The epidemiology of IBD patients has not been comprehensively studied in EMRO countries; therefore, we conducted this meta-analysis to study the epidemiology of this disease in these countries.

METHODS

We searched four international databases, namely Scopus, Web of Knowledge (ISI), Medline/PubMed, and ProQuest, from inception up to the end of May 2023. The Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guideline was used to carry out this systematic review and meta-analysis investigation. Using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist, the quality of the selected papers was assessed.

RESULTS

Based on the results of this study, the incidence of UC in EMRO countries was 2.65 per 100,000 (95% CI: 1.39-3.90), and the incidence of CD was 1.16 per 100,000 (95% CI: 0.73-1.59). The most commonly involved intestinal segment in CD was the terminal ileum (44.7%, 95% CI: 34.7-55.2), followed by the ileum (29.8%, 95% CI: 22.2-38.6), and colon (18.7%, 95% CI: 10.8-30.4). However, in UC patients, extensive colitis was the most common finding (32.3%, 95% CI: 26.4-38.8), followed by proctosigmoiditis (27.9%, 95% CI: 21.1-35.8), left-sided colitis (27.4%, 95% CI: 22.7-32.7), and proctitis (22.6%, 95% CI: 17.5-28.5).

CONCLUSION

As a result, we were able to establish the traits of IBD patients in EMRO nations. UC patients had a higher incidence than CD patients. The most common regions of involvement in CD and UC patients, respectively, were the colon and pancolitis. Compared to UC patients, CD patients had a higher history of appendectomy.

摘要

背景

炎症性肠病(IBD)包括两种主要类型:克罗恩病(CD)和溃疡性结肠炎(UC)。EMRO 国家的 IBD 患者流行病学尚未得到全面研究;因此,我们进行了这项荟萃分析,以研究这些国家的这种疾病的流行病学。

方法

我们从四个国际数据库(Scopus、Web of Knowledge(ISI)、Medline/PubMed 和 ProQuest)进行了搜索,从成立到 2023 年 5 月底。使用循证医学和荟萃分析的首选报告项目(PRISMA)指南进行了这项系统评价和荟萃分析调查。使用 Joanna Briggs 研究所(JBI)的批判性评价清单评估了选定论文的质量。

结果

根据这项研究的结果,EMRO 国家的 UC 发病率为每 100,000 人 2.65 例(95%CI:1.39-3.90),CD 的发病率为每 100,000 人 1.16 例(95%CI:0.73-1.59)。CD 中最常受累的肠段是末端回肠(44.7%,95%CI:34.7-55.2),其次是回肠(29.8%,95%CI:22.2-38.6)和结肠(18.7%,95%CI:10.8-30.4)。然而,在 UC 患者中,广泛性结肠炎是最常见的发现(32.3%,95%CI:26.4-38.8),其次是直肠乙状结肠炎(27.9%,95%CI:21.1-35.8),左侧结肠炎(27.4%,95%CI:22.7-32.7)和直肠炎(22.6%,95%CI:17.5-28.5)。

结论

因此,我们能够确定 EMRO 国家 IBD 患者的特征。UC 患者的发病率高于 CD 患者。CD 和 UC 患者分别最常见受累的区域是结肠和全结肠炎。与 UC 患者相比,CD 患者有更高的阑尾切除术史。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/ab559f77de76/12889_2024_18816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/10948b23c0e3/12889_2024_18816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/78e02d19588d/12889_2024_18816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/ab559f77de76/12889_2024_18816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/10948b23c0e3/12889_2024_18816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/78e02d19588d/12889_2024_18816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b552/11127456/ab559f77de76/12889_2024_18816_Fig3_HTML.jpg

相似文献

1
Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis.中东地区(EMRO)国家炎症性肠病的流行病学特征:系统评价和荟萃分析。
BMC Public Health. 2024 May 24;24(1):1395. doi: 10.1186/s12889-024-18816-z.
2
A systematic review and meta-analysis of extra-intestinal manifestation of inflammatory bowel disease in the Eastern Mediterranean Region (EMRO) countries.东地中海区域(EMRO)国家炎症性肠病肠外表现的系统评价与荟萃分析。
Ann Med Surg (Lond). 2024 Apr 15;86(5):2892-2899. doi: 10.1097/MS9.0000000000001543. eCollection 2024 May.
3
A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.一项针对马来西亚吉隆坡单一三级医疗中心炎症性肠病患者发病率趋势、社会人口学和临床特征的四十年分析。
BMC Public Health. 2019 Jun 13;19(Suppl 4):550. doi: 10.1186/s12889-019-6858-2.
4
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.欧洲炎症性肠病发病率的东西梯度:ECCO-EpiCom 起始队列。
Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.
5
Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.哥伦比亚基于全国代表性索赔数据库的人口统计学和地区炎症性肠病流行病学趋势以及对哥伦比亚患者病例系列中炎症性肠病表型的特征描述。
Medicine (Baltimore). 2021 Feb 19;100(7):e24729. doi: 10.1097/MD.0000000000024729.
6
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.南亚、东南亚和中东地区炎症性肠病的新发病情况、表型及治疗:炎症性肠病新兴国家联盟的初步研究结果
J Gastroenterol Hepatol. 2022 Jun;37(6):1004-1015. doi: 10.1111/jgh.15801. Epub 2022 Mar 17.
7
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.21 世纪克罗恩病和溃疡性结肠炎的全球住院治疗趋势:一项具有时间分析的系统评价。
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2211-2221. doi: 10.1016/j.cgh.2022.06.030. Epub 2022 Jul 19.
8
Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.50 年来英国卡迪夫炎症性肠病发病和临床特征的变化:2005-2016 年更新。
Scand J Gastroenterol. 2023 Jun;58(6):619-626. doi: 10.1080/00365521.2022.2158754. Epub 2022 Dec 23.
9
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
10
The Epidemiology of Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis of Incidence and Prevalence.大洋洲炎症性肠病的流行病学:发病率和患病率的系统评价和荟萃分析。
Inflamm Bowel Dis. 2024 Nov 4;30(11):2076-2086. doi: 10.1093/ibd/izad295.

引用本文的文献

1
The Interplay of Coping Strategies and Quality of Life in Inflammatory Bowel Disease: A Systematic Review.炎症性肠病中应对策略与生活质量的相互作用:一项系统综述
Middle East J Dig Dis. 2025 Jan;17(1):60-67. doi: 10.34172/mejdd.2025.409. Epub 2025 Jan 31.
2
Exploring the Immunological Role of the Microbial Composition of the Appendix and the Associated Risks of Appendectomies.探索阑尾微生物组成的免疫作用及阑尾切除术的相关风险。
J Pers Med. 2025 Mar 14;15(3):112. doi: 10.3390/jpm15030112.
3
Alterations of the Gut Microbiome and TMAO Levels in Patients with Ulcerative Colitis.

本文引用的文献

1
Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis.家族癌症史作为 EMRO 国家结直肠癌潜在风险因素的系统评价和荟萃分析。
Sci Rep. 2023 Oct 14;13(1):17457. doi: 10.1038/s41598-023-44487-8.
2
Association between smoking and colorectal cancer in Eastern Mediterranean Regional Office (EMRO): A systematic review and meta-analysis.吸烟与东地中海区域办事处(EMRO)结直肠癌的关系:系统评价和荟萃分析。
Saudi J Gastroenterol. 2023 Jul-Aug;29(4):204-211. doi: 10.4103/sjg.sjg_163_23.
3
Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy.
溃疡性结肠炎患者肠道微生物群和氧化三甲胺水平的改变
J Clin Med. 2024 Sep 28;13(19):5794. doi: 10.3390/jcm13195794.
炎症性肠病的流行病学:意大利西北部一个医疗区的人群研究
J Clin Med. 2023 Jan 13;12(2):641. doi: 10.3390/jcm12020641.
4
Appendectomy and risk for inflammatory bowel disease: effect of age and time post appendectomy - a cohort study.阑尾切除术与炎症性肠病风险:年龄和阑尾切除术后时间的影响-队列研究。
BMJ Open Gastroenterol. 2022 Jul;9(1). doi: 10.1136/bmjgast-2022-000925.
5
Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood.成年期阑尾切除术后患炎症性肠病的风险。
Front Med (Lausanne). 2021 Jun 2;8:661752. doi: 10.3389/fmed.2021.661752. eCollection 2021.
6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
7
The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database.英国初级医疗中炎症性肠病的发病率和患病率:一项对艾昆纬医学研究数据库的回顾性队列研究
BMC Gastroenterol. 2021 Mar 26;21(1):139. doi: 10.1186/s12876-021-01716-6.
8
Estimation the direct cost of inflammatory bowel disease in Iranian patients; the one- year follow-up.估算伊朗炎性肠病患者的直接成本;一年随访
Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S87-S93.
9
Does the inflammatory potential of diet affect disease activity in patients with inflammatory bowel disease?饮食的炎症潜能是否会影响炎症性肠病患者的疾病活动度?
Nutr J. 2019 Nov 4;18(1):65. doi: 10.1186/s12937-019-0492-9.
10
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年炎症性肠病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21.